NO993124L - Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner - Google Patents

Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner

Info

Publication number
NO993124L
NO993124L NO993124A NO993124A NO993124L NO 993124 L NO993124 L NO 993124L NO 993124 A NO993124 A NO 993124A NO 993124 A NO993124 A NO 993124A NO 993124 L NO993124 L NO 993124L
Authority
NO
Norway
Prior art keywords
medicines
nar
processes
preparation
erythromycin derivatives
Prior art date
Application number
NO993124A
Other languages
English (en)
Other versions
NO993124D0 (no
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO993124D0 publication Critical patent/NO993124D0/no
Publication of NO993124L publication Critical patent/NO993124L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Forbindelser med formel (I) hvor X betegner en CH2- eller NH- gruppe, R betegner et (CH2)nAR-, N- (CH2)nAr- eller N=CH(CH2)nAr-radikal der ¿ betegner et helt tall mellom l og 6 og Ar betegner en aryl- eller heteroaryl- gruppe, eventuelt substituert, den stiplede linje betegner en eventuell dobbeltbinding i posisjon 2 (3), og Y betegner et hydrogenatom eller et organisk karboksylsyreradikal inneholdende opptil 18 karbonatomer, og deres addisjonssalter med syrer. Forbindelsene med formel (I) har antibiotiske egenskaper som gjør dem anvendelige som medisiner.
NO993124A 1996-12-23 1999-06-23 Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner NO993124L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615830A FR2757518B1 (fr) 1996-12-23 1996-12-23 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/002380 WO1998028316A1 (fr) 1996-12-23 1997-12-22 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
NO993124D0 NO993124D0 (no) 1999-06-23
NO993124L true NO993124L (no) 1999-08-20

Family

ID=9498984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993124A NO993124L (no) 1996-12-23 1999-06-23 Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner

Country Status (24)

Country Link
EP (1) EP0946580B1 (no)
JP (2) JP4522496B2 (no)
KR (1) KR20000062286A (no)
CN (1) CN1246123A (no)
AP (1) AP9901566A0 (no)
AT (1) ATE215553T1 (no)
AU (1) AU726147B2 (no)
BR (1) BR9713618A (no)
CA (1) CA2275359A1 (no)
CZ (1) CZ293732B6 (no)
DE (1) DE69711689T2 (no)
DK (1) DK0946580T3 (no)
EA (1) EA199900589A1 (no)
ES (1) ES2172827T3 (no)
FR (1) FR2757518B1 (no)
HU (1) HUP0001452A3 (no)
ID (1) ID21883A (no)
IL (1) IL130510A0 (no)
NO (1) NO993124L (no)
PL (1) PL334134A1 (no)
PT (1) PT946580E (no)
SK (1) SK83199A3 (no)
TR (1) TR199901452T2 (no)
WO (1) WO1998028316A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
US6720308B1 (en) * 2002-11-07 2004-04-13 Enanta Pharmaceuticals, Inc. Anhydrolide derivatives having antibacterial activity
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
JPH0853355A (ja) * 1994-08-12 1996-02-27 Taisho Pharmaceut Co Ltd Ｉｌ−５産生抑制剤
PT874863E (pt) * 1995-11-08 2003-06-30 Abbott Lab Derivados 3-desoxi-3-descladinose de eritromicinasa e b
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DK0946580T3 (da) 2002-07-22
HU0001452B (hu) 2000-09-28
CN1246123A (zh) 2000-03-01
FR2757518A1 (fr) 1998-06-26
TR199901452T2 (xx) 1999-10-21
CA2275359A1 (fr) 1998-07-02
JP4522496B2 (ja) 2010-08-11
PT946580E (pt) 2002-09-30
JP2010132683A (ja) 2010-06-17
AU5667998A (en) 1998-07-17
ES2172827T3 (es) 2002-10-01
JP2001507011A (ja) 2001-05-29
FR2757518B1 (fr) 1999-06-11
PL334134A1 (en) 2000-02-14
SK83199A3 (en) 2000-05-16
DE69711689D1 (de) 2002-05-08
ID21883A (id) 1999-08-05
EA199900589A1 (ru) 2000-02-28
WO1998028316A1 (fr) 1998-07-02
KR20000062286A (ko) 2000-10-25
JP5188520B2 (ja) 2013-04-24
CZ227999A3 (cs) 1999-10-13
NO993124D0 (no) 1999-06-23
HUP0001452A3 (en) 2000-10-30
ATE215553T1 (de) 2002-04-15
EP0946580A1 (fr) 1999-10-06
DE69711689T2 (de) 2002-10-17
AP9901566A0 (en) 1999-06-30
CZ293732B6 (cs) 2004-07-14
AU726147B2 (en) 2000-11-02
BR9713618A (pt) 2000-04-11
IL130510A0 (en) 2000-06-01
EP0946580B1 (fr) 2002-04-03

Similar Documents

Publication Publication Date Title
NO923466L (no) Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
NO970175L (no) Pyrido-annellerte tienyl- og furanyl-oksazolidinoner
EP1103552A4 (en) BENZOTHIEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
ATE282630T1 (de) Dolastatin-derivate
DK0596802T3 (da) Erythromycinderivater, deres fremstilling og deres anvendelse som lægemidler
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
NO20062269L (no) Pyridin-karboksylsyrederivater som glucokinasemodulatorer
NO891698D0 (no) Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling.
MY101208A (en) Phenyl-piperazine anti-arrhythmia agents.
NO922185L (no) 1-metylkarbapenemderivater, fremgangsmaate til fremstilling derav, samt anvendelse av derivatene som antibiotika
DE69627985D1 (de) Heterozyklische verbindungen
NO944121L (no) Epoksyravsyrederivater
NO993124L (no) Nye erytromycinderivater, fremgangsmåte for fremstilling av disse samt deres anvendelse som medisiner
DE69329385D1 (de) Thiazolin-derivate
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
NO20053302D0 (no) Imidazolderivater med affinitet for alfa 2-reseptoraktivitet.
NO994150L (no) Nye derivater av erytromycin, fremgangsmaate for ffemstilling av disse og deres anvendelse som medikamenter
EA199900528A1 (ru) Новые производные эритромицина, способ их получения и применения в качетве медикаментов
NO920619L (no) Oxazinobenzazolforbindelser
AU560621B2 (en) Polymethylene imine substituted triazines
NO980994L (no) Substituerte fosfinsyreforbindelser og deres anvendelse som farmas÷ytika
DK1098901T3 (da) Nye 6-deoxyerythromycinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
ES8604233A1 (es) Procedimiento de preparacion de sales sodicas de antibioticos beta-lactamicos
TR199901705T2 (xx) Trisiklik karbapenem bile�ikleri.
EP1151993A4 (en) CYCLIC AMINE DERIVATIVES AND THEIR APPLICATIONS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application